|
2024
|
Invention
|
Gspt1 degrader compounds. The present invention provides a compound of formula (I) and a pharmace... |
|
2023
|
Invention
|
Targeted protein degradation using prodrugs of bifunctional compounds that bind ubiquitin ligase ... |
|
|
Invention
|
Nek7 degraders and methods of use thereof. The present invention provides compounds of Formula (I... |
|
|
Invention
|
Gspt1 degrader compounds. The present invention provides a compound of formula I and a pharmaceut... |
|
2022
|
Invention
|
Nek7 degraders and methods of use thereof. The present invention provides compounds of Formula (l... |
|
|
Invention
|
Targeted protein degradation using bifunctional compounds that bind ubiquitin ligase and target m... |
|
2021
|
Invention
|
Novel compounds which bind to cereblon, and methods of use thereof.
The present invention disclo... |
|
|
Invention
|
Novel compounds which bind to cereblon, and methods of use thereof. The present invention disclos... |
|
|
Invention
|
Low molecular weight protein degraders and their applications.
The invention relates to compound... |
|
|
Invention
|
Low molecular weight protein degraders and their applications. The invention relates to compounds... |
|
|
Invention
|
Compounds which bind to cereblon, and use thereof. The present invention provides novel compounds... |
|
2020
|
Invention
|
Piperidine-2,6-dione derivatives which bind to cereblon, and methods of use thereof.
The present... |
|
|
Invention
|
Piperidine-2, 6-dione derivatives which bind to cereblon, and methods of use thereof. The present... |
|
2019
|
P/S
|
Food supplements; Veterinary preparations; Pharmaceutical preparations. Scientific research in th... |
|
2017
|
P/S
|
Scientific research relating to chemistry; Scientific research relating to cosmetics; Scientific ... |
